Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area pi3k akt signaling akt'

Search results for: 'research area pi3k akt signaling akt'

Items 61-70 of 132

Page
per page
  1. BIX 02189
    A5801 BIX 02189
    Target: MEK|ERK
    Summary: Selective MEK5 inhibitor
      ≥22.05 mg/mL
  2. GF 109203X
    A8342 GF 109203X
     1 Citation
    Target: PKC
    Summary: Protein kinase C,MLCK,PKG and PKA inhibitor
      insoluble in EtOH; insoluble in H2O; ≥20.6 mg/mL
  3. K-252c
    A8344 K-252c
    Target: PKC|PKA
    Summary: Protein kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥15.55 mg/mL
  4. Vemurafenib (PLX4032, RG7204)
    A3004 Vemurafenib (PLX4032, RG7204)
     9 Citation
    Target: Raf
    Summary: BRAF kinase inhibitor
      ≥24.5 mg/mL
  5. (-)-Epigallocatechin gallate (EGCG)
    A2600 (-)-Epigallocatechin gallate (EGCG)
    Target: BACE
    Summary: Antioxidant, antiangiogenic and antitumor agent
      ≥22.9 mg/mL
  6. NSC 74859
    A8338 NSC 74859
     5 Citation
    Target: STAT
    Summary: Stat3 inhibitor
      insoluble in H2O; ≥18.25 mg/mL
  7. GW788388
    A8301 GW788388
    Summary: ALK5 inhibitor,potent and selective
      ≥21.25 mg/mL
  8. RAF265
    A8313 RAF265
    Target: Raf|VEGFR
    Summary: Multiple intracellular kinases inhibitor
      ≥25.9 mg/mL
  9. LY2157299
    A8348 LY2157299
     2 Citation
    Summary: TGF-βR1 inhibitor,potent and selective
      insoluble in H2O; ≥18.45 mg/mL
  10. LY2109761
    A8464 LY2109761
     4 Citation
    Summary: TβRI/II kinase inhibitor
      ≥22.1 mg/mL

Items 61-70 of 132

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Natural Products 1 item
Specificity
  1. Selective 90item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 7item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 12item
  4. PI3K 29item
  5. Raf 8item
  6. Aurora Kinases 1 item
  7. mTOR 15item
  8. Androgen Receptors 1 item
  9. FLT3 1 item
  10. GSK-3 6item
  11. P-glycoprotein (P-gp) 1 item
  12. PLK 1 item
  13. VEGFR 5item
  14. PDGFR 1 item
  15. Phosphodiesterases (PDEs) 1 item
  16. p38 4item
  17. PKB 1 item
  18. JNK 2item
  19. MEK 4item
  20. PORCN 1 item
  21. FGFR 1 item
  22. GABAB Receptors 1 item
  23. Smoothened 1 item
  24. NMDA Receptors 1 item
  25. STAT 6item
  26. EGFR 2item
  27. Hedgehog 1 item
  28. BMP and Other Activin Receptors 2item
  29. JAK 3item
  30. Syk 1 item
  31. DNA-PK 5item
  32. HSP90 1 item
  33. TNKS 1 item
  34. Toll-like receptors (TLRs) 1 item
  35. ERK 2item
  36. PKC 6item
  37. Melanocortin (MC) Receptors 1 item
  38. ALK 1 item
  39. PKG 1 item
  40. PKA 4item
  41. Fatty-acid-binding proteins (FABPs) 1 item
  42. RSK 1 item
  43. Histamine H1 Receptors 1 item
  44. NO Donors / Precursors 1 item
  45. IL Receptors 1 item
  46. AChE 1 item
  47. BACE 1 item
  48. p70 rsk 1 item
  49. Smoothened receptor 1 item
  50. Antibiotic 1 item
  51. Prk 1 item
  52. ICAM 1 item
  53. Rho 1 item
  54. Thrombin Receptor 1 item
  55. prolactin secretion 1 item
  56. gonadotropin release 1 item
  57. TRPC channel 1 item
  58. PKD 1 item
  59. FKBP 1 item
  60. ATM 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 2item
  3. Bladder Cancer 1 item
  4. Breast Cancer 24item
  5. Cancer 85item
  6. Cervical Cancer 2item
  7. Cholangiocarcinoma 1 item
  8. Chronic Lymphocytic Leukemia 1 item
  9. Colon Cancer 10item
  10. Colon Carcinoma 1 item
  11. Colorectal Cancer 11item
  12. Glioblastoma 10item
  13. Glioma 4item
  14. Heart Failure 1 item
  15. Hepatocellular Carcinoma 1 item
  16. Leukemia 6item
  17. Liver Cancer 1 item
  18. Lung Cancer 7item
  19. Lymphoma 2item
  20. Melanoma 7item
  21. Multiple Myeloma 1 item
  22. Myeloma 1 item
  23. Neuroblastoma 2item
  24. Non-small Cell Lung Cancer 6item
  25. Ovarian Cancer 7item
  26. Pancreatic Cancer 9item
  27. Pancreatic Carcinoma 2item
  28. Prostate Cancer 11item
  29. Pulmonary Arterial Hypertension 1 item
  30. Pulmonary Fibrosis 1 item
  31. Renal Cancer 2item
  32. Rheumatoid Arthritis 2item
  33. Thyroid Cancer 2item
  34. Type 2 Diabetes 2item